S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RA Capital Management/Q4 2021

RA Capital Management

Period: Q4 2021 Β· Filed: 2022-02-14
View on SEC EDGAR β†—
AUM
$5.67B
Total portfolio value
Positions
97
Reported securities
Top Holding
ASND
17.9% $1.02B
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-02-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ASNDASCENDIS PHARMA A/S$1.02B17.95%$134.53$274.50+104.0%
17.9%
NVAXNOVAVAX INC$300.1M5.29%$143.07$9.74-93.2%
5.3%
ITOSITEOS THERAPEUTICS INC$205.7M3.63%β€”β€”
3.6%
TVTXTRAVERE THERAPEUTICS INC$174.3M3.07%$31.04$56.92+83.4%
3.1%
JANXJANUX THERAPEUTICS INC$171.1M3.02%$19.73$15.54-21.2%
3.0%
CTKBCYTEK BIOSCIENCES INC$156.8M2.76%$16.32$4.59-71.9%
2.8%
IMGNIMMUNOGEN INC$150.2M2.65%β€”β€”
2.6%
CLYMELIEM THERAPEUTICS INC$137.6M2.43%$10.46$12.90+23.3%
2.4%
ICVXICOSAVAX INC$132.2M2.33%β€”β€”
2.3%
DICEDICE THERAPEUTICS INC$131.8M2.32%β€”β€”
2.3%
VORXXXXVOR BIOPHARMA INC$129.2M2.28%β€”β€”
2.3%
FMTXFORMA THERAPEUTICS$128.2M2.26%β€”β€”
2.3%
TYRATYRA BIOSCIENCES INC$101.8M1.80%$14.07$30.62+117.6%
1.8%
PCVXVAXCYTE INC$100.9M1.78%$23.79$58.39+145.4%
1.8%
MGNXMACROGENICS INC$98.0M1.73%$16.05$4.71-70.7%
1.7%
AVTEAEROVATE THERAPEUTICS INC$97.4M1.72%β€”β€”
1.7%
NKTXNKARTA INC$86.0M1.52%$15.35$3.22-79.0%
1.5%
DAWNDAY ONE BIOPHARMACEUTICALS$83.7M1.48%β€”β€”
1.5%
TILINSTIL BIO INC$83.3M1.47%$342.20$7.73-97.7%
1.5%
BLUBELLUS HEALTH INC NEW$82.3M1.45%β€”β€”
1.4%
CLDXCELLDEX THERAPEUTICS INC NEW$69.7M1.23%$38.64$38.37-0.7%
1.2%
TNYATENAYA THERAPEUTICS INC$67.3M1.19%$18.95$0.79-95.8%
1.2%
GHRSGH RESEARCH PLC$66.3M1.17%$23.33$27.01+15.8%
1.2%
ABOSACUMEN PHARMACEUTICALS INC$66.0M1.16%$6.76$2.74-59.5%
1.2%
ETNB89BIO INC$64.9M1.14%β€”β€”
1.1%
KNTEKINNATE BIOPHARMA INC$63.7M1.12%β€”β€”
1.1%
PHATPHATHOM PHARMACEUTICALS INC$61.3M1.08%$19.67$11.20-43.1%
1.1%
MRTXMIRATI THERAPEUTICS INC$55.9M0.99%β€”β€”
1.0%
ZGNXZOGENIX INC$54.2M0.96%β€”β€”
1.0%
PRDSPARDES BIOSCIENCES INC$51.2M0.90%β€”β€”
0.9%

Quarter-on-Quarter Activity

Q4 2021 vs. Q3 2021

New Positions (8)

TickerIssuerNotional
BLUBELLUS HEALTH INC NEW$82.3M
MRTXMIRATI THERAPEUTICS INC$55.9M
PRDSPARDES BIOSCIENCES INC$51.2M
LIANYLIANBIO$47.2M
RLMDRELMADA THERAPEUTICS$45.1M
XLOXILIO THERAPEUTICS INC$32.0M
PYXSPYXIS ONCOLOGY INC$25.0M
RLAYRELAY THERAPEUTICS INC$16.9M

Exited Positions (8)

TickerIssuerNotional
AVIRATEA PHARMACEUTICALS INC$190.3M
CTMXCYTOMX THERAPEUTICS INC$17.8M
WHWKAADI BIOSCIENCES INC$10.2M
FSIIFS DEVELOPMENT CORP II$9.9M
OCULOCULAR THERAPEUTIX INC$7.5M
HLXAHELIX ACQUISITION CORP$7.0M
CCXICHEMOCENTRYX INC$3.7M
RPHMRENEO PHARMACEUTICALS INC$0.5M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
OTICOTONOMY INC$8.5M+243.2%
EYPTEYEPOINT PHARMACEUTICALS$18.2M+52.5%
CLDXCELLDEX THERAPEUTICS INC NEW$-16.6M+12.8%-0.7%
IMGNIMMUNOGEN INC$45.8M+9.9%
PCVXVAXCYTE INC$2.0M+8.8%+145.4%
MGNXMACROGENICS INC$-26.5M+2.7%-70.7%
ASNDASCENDIS PHARMA A/S$-159.4M+2.4%+104.0%
PNTPOINT BIOPHARMA GLOBAL INC$-17.7M+1.7%

Trimmed (7)

TickerIssuerNotionalShares Ξ”Since Filing
VERVVERVE THERAPEUTICS INC$-29.9M-64.8%
TGTXTG THERAPEUTICS INC$-94.4M-46.1%
ORTXORCHARD THERAPEUTICS PLC$-12.6M-12.1%
LRMRLARIMAR THERAPEUTICS INC$-3.1M-11.9%
IVVDADAGIO THERAPEUTICS INC$-189.3M-6.4%
GHRSGH RESEARCH PLC$-0.1M-5.6%+15.8%
SCPHSCPHARMACEUTICALS$-4.7M-1.4%
← Back to Hedge Funds